Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): prevalence, therapeutic innovations, and stumbling blocks for clinical development
- PMID: 31971024
- DOI: 10.1080/13543784.2020.1721167
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): prevalence, therapeutic innovations, and stumbling blocks for clinical development
Keywords: NAFLD; nash; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; obeticholic acid; regenerate trial; type-2 diabetes.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical